Collectively, the findings of the present study underscore DUSP26 as a promising therapeutic target for DDH‐associated osteoarthritis, offering novel mechanistic insights and laying the groundwork for the development of targeted interventions to mitigate secondary joint degeneration. This evidence concerns the gene DUSP26 and osteoarthritis.